Filing Flows › Syra Health (SYRA) › Q3 2026
Syra Health (SYRA) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 3, 2026
Syra Health (SYRA) reported revenue of $2.6M for the third quarter 2026 (Q3 2026), +52% from a year earlier and +7% from the quarter before. Operating margin was 11.7%, net earnings $345K (13.5% of revenue).
Syra Health, Q3 2026: revenue $2.6M (+52% year over year), operating margin 11.7%, net earnings $345K, operating cash flow $332K. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.6M | +7% | +52% |
| Gross profit | $1.2M | +11% | +114% |
| Operating profit | $300K | +19% | — |
| Net earnings | $345K | +38% | — |
| Operating cash flow | $332K | — | — |
What changed
Revenue was $2.6M in Q3 2026, up 52% year over year and up 7% from the previous quarter. Population Health was the largest line at 76% of revenue. Population Health added $664K year over year (up 52%), 76% of the total change.
Gross margin was 46.3%, up 13.5 points from Q3 2025. Operating profit was $300K, a 11.7% margin (up 25.5 points year over year). Operating expenses grew 12% against revenue growth of 52%. The fastest-growing cost line was Research & development (+5625%). Net earnings were $345K. The effective tax rate was -15.0%.
Operating cash flow was $332K, 96% of net earnings. Non-cash charges added back $1K of depreciation and $45K of share-based compensation. Working capital and other items used $59K.
Questions
What was Syra Health's revenue in the third quarter 2026?
Syra Health (SYRA) reported revenue of $2.6M for the third quarter 2026 (Q3 2026), +52% from a year earlier and +7% from the quarter before.
Was Syra Health profitable in the third quarter 2026?
Operating profit was $300K (11.7% of revenue) and net earnings $345K.
Source: Syra Health 10-Q on SEC EDGAR.